4th Quarter - Report

ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY

Firm
Client
Income
—
Expenses
$230,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Support for increased FDA funding

LobbyistCovered position, as disclosed
REGINIA GRAYSON BENJAMIN —
ADAM PARKER NELSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC)

Medicare/Medicaid MMM

21st century cures (HR 6), Medicare Part D pharmacy drug management programs for at-risk beneficiaries (S. 1913),Biosimilar naming, Medicare Part D, AMCP draft legislation - "Medicare Prescription Drug Anti-Fraud Act", Medicare Part B reimbursement of biosimilars, Senate Innovations Initiative and Medication Therapy Management (MTM)

LobbyistCovered position, as disclosed
REGINIA GRAYSON BENJAMIN —
ADAM PARKER NELSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1913 (114th), H.R. 6 (114th)

Pharmacy PHA

Biosimilar naming - supporting Congressional action to seek FDA decision on naming and supporting FTC study of effect of naming on competition, Medicare Part D lock in and Medicare Part D issues concerning managed care pharmacy, providing comments to the FDA on the impact of Risk Evaluation Mitigation Strategies (REMS), supporting H.R. 2841 designed to increase access to generic drugs and providing comments to CMS on benefit and payment parameters for 2017.

LobbyistCovered position, as disclosed
REGINIA GRAYSON BENJAMIN —
ADAM PARKER NELSON —

Contacted: Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2841 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.